Diagnostic Value of Serum and Salivary Podoplanin as Clinical Biomarkers for Distinguishing Oral Cancer from Oral Leukoplakia
Diagnostics · 09.01.2026 · 16 (2) · 206
DOI: 10.3390/diagnostics16020206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 09.01.2026. Verfasst von Hafize Uzun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34303 Istanbul, Turkey. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Research Council of Türkiye (TÜBİTAK)–2209/A Undergraduate Research Support Program.
Abstract (Originalsprache)
Objective
This study aimed to evaluate serum and salivary podoplanin (PDPN) levels in patients with oral cancer (OC) and oral leukoplakia (OL) and to investigate their potential role as diagnostic biomarkers in distinguishing between these conditions. Materials and Method: Ninety participants were enrolled: 30 healthy controls, 30 patients with OL, and 30 patients with histopathologically confirmed OC. All cases were recruited from the Department of Otorhinolaryngology, Cerrahpaşa Medical Faculty and Istanbul Atlas University Hospital. Demographic characteristics, comorbidities, and biochemical parameters were recorded. Serum and salivary PDPN levels were measured using the ELISA method.
Results
Serum PDPN levels were significantly higher in the OC group (3.25 ± 0.80 ng/mL) compared with both OL (1.85 ± 0.56 ng/mL) and controls (0.98 ± 0.42 ng/mL) (p < 0.001). Salivary PDPN levels showed a similar pattern, being highest in OC (2.65 ± 0.75 ng/mL), followed by leukoplakia (1.40 ± 0.45 ng/mL), and controls (0.72 ± 0.30 ng/mL) (p < 0.001). Importantly, both serum and salivary PDPN concentrations increased progressively with increasing epithelial dysplasia severity among patients with OL (one-way ANOVA, p < 0.001). ROC analysis demonstrated excellent diagnostic accuracy for OC: AUC = 0.976 for serum PDPN (cut-off: 2.0 ng/mL; sensitivity 93.3%, specificity 100%) and AUC = 0.987 for salivary PDPN (cut-off 1.24 ng/mL; sensitivity 93.3%, specificity 95%).
Conclusions
Serum and salivary PDPN levels were significantly elevated in patients with OC and demonstrated excellent diagnostic performance in distinguishing malignant lesions from OL and healthy controls. The observed stepwise increase in PDPN levels with dysplasia severity further supports its role in malignant transformation. Notably, salivary PDPN represents a non-invasive, practical, and reproducible biomarker that may aid in early detection and risk stratification of high-risk oral premalignant lesions. PDPN assessment could therefore complement clinical and histopathological evaluation, although larger prospective studies are warranted to validate its diagnostic and prognostic utility.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34303 Istanbul, Turkey.
- Faculty of Dentistry, Istanbul Atlas University, 34303 Istanbul, Turkey.
- Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Istanbul Atlas University, 34303 Istanbul, Turkey.
- Department of Biochemistry, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.
- Department of Otolaryngology Head and Neck Surgery, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.
ORCID-Profile: Hafize Uzun, Guven Bozarslan, Naile Fevziye Misirlioglu, Aysegul Batioglu Karaaltin, Yetkin Zeki Yilmaz
Förderung
- Scientific and Technological Research Council of Türkiye (TÜBİTAK)–2209/A Undergraduate Research Support Program
Zitieren
APA
Uzun, H., Bozarslan, G., Dumur, S., Misirlioglu, N. F., Elgormus, M. N., Duvarcı, C., Gelisgen, R., Karaaltin, A. B., & Yilmaz, Y. Z. (2026). Diagnostic Value of Serum and Salivary Podoplanin as Clinical Biomarkers for Distinguishing Oral Cancer from Oral Leukoplakia. Diagnostics, 16(2), 206. https://doi.org/10.3390/diagnostics16020206
Vancouver
Uzun H, Bozarslan G, Dumur S, Misirlioglu NF, Elgormus MN, Duvarcı C, et al. Diagnostic Value of Serum and Salivary Podoplanin as Clinical Biomarkers for Distinguishing Oral Cancer from Oral Leukoplakia. Diagnostics. 2026;16(2):206. doi:10.3390/diagnostics16020206
BibTeX
@article{Uzun2026,
author = {Uzun, Hafize and Bozarslan, Guven and Dumur, Seyma and Misirlioglu, Naile Fevziye and Elgormus, Mehmet Nuri and Duvarcı, Canan and Gelisgen, Remise and Karaaltin, Aysegul Batioglu and Yilmaz, Yetkin Zeki},
title = {Diagnostic Value of Serum and Salivary Podoplanin as Clinical Biomarkers for Distinguishing Oral Cancer from Oral Leukoplakia},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {2},
pages = {206},
doi = {10.3390/diagnostics16020206}
}
EUVIMED